Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Intrauterine Contraceptive Devices (IUD) Market

  • MAR2979432
  • 180 Pages
  • May 2018
  • Pharmaceuticals
Download Sample    Get Discount   
 
The Global Intrauterine Contraceptive Devices (IUD) Market was valued at US$ XX Mn in 2016 and is expected to reach US$ XX Mn by 2022 growing at a CAGR of XX% during the forecast period.

IUDs are small contraceptive devices, often T-shaped, containing either copper or levonorgestrel, helping in birth control for an extended period of time. They are a form of long-acting contraception and are the most effective type of reversible birth control. The approximate tenure of these devices lies between 5 to 8 years.

Market Dynamics

The global contraceptives market is estimated to witness a considerable growth during the forecast period.

Drivers/ Growth Factors

--> Increased rate of unplanned pregnancies

--> Rising prevalence of sexually transmitted diseases

--> Technological advancements in female contraceptive drugs & devices

--> No need for a new contraception every day, as in case of contraceptive pills

--> Increasing government and NGO initiatives to promote contraceptives

--> Growing public awareness

Restraints/ Challenge

--> Rising concern of infertility

--> Threat of Pelvic Inflammatory Infection (PFD)

--> Danger of ectopic pregnancy; in which the fetus develops outside the uterus, typically in a fallopian tube

--> May lead to heavy menstrual bleeding resulting into painful cramps

--> Cultural or religious oppositions prevalent in many countries

--> Economic constraints

Opportunities

--> New products are in the research pipeline

--> Shows that IUDs are the safest contraceptives are some of the market opportunities for the key players.

Market Segmentation

The global market for IUD is segmented on the basis of type, product, end use and geography. On the basis of type, the market is classified under copper intrauterine device and hormonal intrauterine device market. On the basis of product, the market is segmented into MIRENA, ESSURE, SKYLA, LEVOSERT, PARAGARD and others.

Based on end use, intrauterine contraceptive devices are further segmented into hospital, gynecology clinics and others. Some trends to notice are as following:

--> Copper IUD market is growing with the highest CAGR.

--> Globally Hormonal IUD is leading the market with highest market share. However, Copper IUD is growing with highest CAGR.

--> North America is leading the intra-uterine contraceptive devices market.

Regional/Geographic Analysis

On the basis of geography, the global IUD market is segmented into North America (including the USA, Canada, and Mexico), Europe (including France, UK, Germany, Spain, Portugal, Scandinavia and Italy), Asia-Pacific (including India, China, Japan, South Korea, Australia, and New Zealand) and Rest of the World (RoW) (including Latin America and Middle East & Africa).

North America accounts for the largest share of the contraceptives market in 2015. However, Asia is the fastest growing market due to growing awareness among people, increased prevalence of unintended pregnancies and sexually transmitted diseases.

Key Players

Some of the leading companies that are indulging in the production of IUDs are Bayer HealthCare AG, DKT International, Melbea AG, Medicines360 and Egemen International among others.

The report contains comprehensive analysis on:

--> Intrauterine Contraceptive Devices (IUD) Market Segments

--> Intrauterine Contraceptive Devices (IUD) Market Drivers, Restraints and Opportunities

--> Intrauterine Contraceptive Devices (IUD) Market Size & Forecast 2016 to 2022

--> Supply & Demand Value Chain

--> Intrauterine Contraceptive Devices (IUD) Market Current Trends

--> Competition & Major Companies

--> Technology and R&D Status

--> Porters Five Force Analysis

--> Strategic and Critical Success Factor Analysis of Key Players

Regional analysis for Intrauterine Contraceptive Devices (IUD) Market includes

--> North America

>> US and Canada

--> Latin America

>> Mexico, Brazil, Argentina and Rest of Latin America

--> Western Europe

>> EU5 (Germany, France, Italy, Spain, U.K.)

>> Nordic Countries (Denmark, Finland, Norway, and Sweden)

>> Benelux (Belgium, The Netherlands, and Luxembourg)

>> Rest of Western Europe

--> Eastern Europe

>> Russia

>> Poland

>> Rest of Eastern Europe

--> Asia Pacific

>> China

>> India

>> Japan

>> Australia and New Zealand

>> Rest of Asia Pacific

--> Middle East and Africa

>> GCC countries (Saudi Arabia, Oman, Qatar, Bahrain, UAE and Kuwait)

>> South Africa

>> North Africa

>> Rest of Middle East and Africa

This report is an elaborate aggregation of primary inputs from industry experts and participants across the supply chain. It provides in-depth market segmentation that is derived from extensive product mapping exercises, macro-economic factors and other qualitative and quantitative insights. The impact of all such factors are delivered across multiple market segments and geographies.

Report Highlights::

--> Detailed Historical Overview (Market Origins, Product Launch Timeline, etc.)

--> Consumer and Pricing Analysis

--> Market dynamics of the industry

--> In-depth Market Segmentation

--> Historical and Projected Market Sizing in terms of volume and value

--> Recent market trends and Impact Factors

--> R&D Status and Technology Overview

--> Extensive Industry Structure Coverage

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

Protein Therapeutics Market by Product (Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, and Follicle Stimulating Hormone) and Application (Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...

  • Publish Date: November 14, 2017
  • $5370
Global Cord Blood Banking Services (Stem Cell) Market, Size, Share, Trends, Forecast, Global Analysis, Research, Report, Segmentation, and Future Demand, 2012 - 2020

Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...

  • Publish Date: July 20, 2017
  • $5370